Maschmeyer, G., Bullinger, L., Garcia-Vidal, C., Herbrecht, R., Maertens, J., Menna, P., . . . Calandra, T. (2022). Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN). Leukemia, 36(5), 1215. https://doi.org/10.1038/s41375-022-01556-7
Chicago-referens (17:e uppl.)Maschmeyer, Georg, Lars Bullinger, Carolina Garcia-Vidal, Raoul Herbrecht, Johan Maertens, Pierantonio Menna, Livio Pagano, Anne Thiebaut-Bertrand, och Thierry Calandra. "Infectious Complications of Targeted Drugs and Biotherapies in Acute Leukemia. Clinical Practice Guidelines by the European Conference on Infections in Leukemia (ECIL), a Joint Venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN)." Leukemia 36, no. 5 (2022): 1215. https://doi.org/10.1038/s41375-022-01556-7.
MLA-referens (9:e uppl.)Maschmeyer, Georg, et al. "Infectious Complications of Targeted Drugs and Biotherapies in Acute Leukemia. Clinical Practice Guidelines by the European Conference on Infections in Leukemia (ECIL), a Joint Venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN)." Leukemia, vol. 36, no. 5, 2022, p. 1215, https://doi.org/10.1038/s41375-022-01556-7.
